BEGIN:VCALENDAR VERSION:2.0 PRODID:-//HCV Free Florida - ECPv6.16.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:HCV Free Florida X-ORIGINAL-URL:https://hcvfreefl.org X-WR-CALDESC:Events for HCV Free Florida REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD TZOFFSETFROM:+0000 TZOFFSETTO:+0000 TZNAME:UTC DTSTART:20200101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Helsinki BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20200329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20201025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20210328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20211031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20221030T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20200329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20201025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20210328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20211031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=UTC:20210929T080000 DTEND;TZID=UTC:20211003T170000 DTSTAMP:20260525T214845 CREATED:20211004T165518Z LAST-MODIFIED:20211004T165518Z UID:653-1632902400-1633280400@hcvfreefl.org SUMMARY:IDWeek 2021 DESCRIPTION:šŸ“¢#IDWeek2021 Featured Speaker! Dr. Harvey Alter of @NIH is one of #IDWeek2021 Closing Plenaries to discuss\, ā€œHepatitis C: The End of the Beginning and Possibly the Beginning of the Endā€. \nšŸ‘‰ See more of this year's program & register: https://t.co/mqD2czb5U5 pic.twitter.com/al7bgjWPiC \nā€” IDWeek (@IDWeekmtg) October 3\, 2021 URL:https://hcvfreefl.org/event/idweek-2021/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211005T180000 DTEND;TZID=UTC:20211005T200000 DTSTAMP:20260525T214845 CREATED:20210922T173608Z LAST-MODIFIED:20210922T173632Z UID:629-1633456800-1633464000@hcvfreefl.org SUMMARY:American Liver Foundation's Southeast Academic Debates 2021 DESCRIPTION:We are so excited for our Southeast Academic Debates coming up with teams from @ClevelandClinic @DukeHealth @EmoryUniversity @MayoClinic @univmiami Medical University of South Carolina\, University of Florida Gainesville and Jacksonville! Register now https://t.co/c6bqeYzkm4 \nā€” American Liver Foundation National (@liverUSA) September 21\, 2021 URL:https://hcvfreefl.org/event/american-liver-foundations-academic-debates/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20211007T083000 DTEND;TZID=Europe/Helsinki:20211008T134500 DTSTAMP:20260525T214845 CREATED:20210826T140610Z LAST-MODIFIED:20210826T140610Z UID:614-1633595400-1633700700@hcvfreefl.org SUMMARY:International Workshop on Liver and Gut Fibrosis DESCRIPTION:Proud to announce the Opening Session of the International Workshop on Liver and Gut Fibrosis: CELLULAR AND MOLECULAR MECHANISMS IN FIBROSIS\, with Frank Tacke & Gerhard Rogler. Valencia 7 Oct šŸ“Œhttps://t.co/bm64bYxyBF #IWLGF2021 #fibrosisvalencia #ibd #livertwitter pic.twitter.com/rcQfi5WtZ7 \nā€” Pharmacology Valencia (@pharmacologyvlc) August 26\, 2021 URL:https://hcvfreefl.org/event/international-workshop-on-liver-and-gut-fibrosis/ LOCATION:ADEIT- FUNDACIƓ UNIVERSITAT-EMPRESA DE VALƈNCIA\, Plaza Virgen de la Paz\, 3\, 46001\, Valencia\, Spain END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211013T080000 DTEND;TZID=UTC:20211015T170000 DTSTAMP:20260525T214845 CREATED:20210817T212336Z LAST-MODIFIED:20210823T162332Z UID:558-1634112000-1634317200@hcvfreefl.org SUMMARY:INHSU 2021 Virtual Conference DESCRIPTION:At #INHSU2021 you'll have the chance to hear from experts in epidemiology and public health in #hepatitisC\, other infectious diseases\, and the broader health of #peoplewhousedrugs. Secure your virtual or in-person ticket today https://t.co/olRs43ZrIc #WorldHepatitisDay pic.twitter.com/1VnhWjYEJO \nā€” INHSU (@INHepSU) July 28\, 2021 URL:https://hcvfreefl.org/event/inhsu-2021-virtual-conference/ LOCATION:Novotel Sydney Manly Pacific\, 55 N Steyne\, Manly NSW 2095\, Australia END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211014T150000 DTEND;TZID=UTC:20211014T160000 DTSTAMP:20260525T214845 CREATED:20210709T165335Z LAST-MODIFIED:20210726T170439Z UID:548-1634223600-1634227200@hcvfreefl.org SUMMARY:Moving from Hepatitis Discovery to Elimination: NIH Webinar Series on Research Advancing Hepatitis Elimination DESCRIPTION:The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020\, Dr. Harvey Alter\, NIH researcher\, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV\, exemplifying the importance of NIH to hepatitis elimination efforts. \nNIH and the Coalition for Global Hepatitis Elimination are launching a new webinar series\, ā€œMoving from Hepatitis Discovery to Eliminationā€ to highlight ongoing research that can benefit elimination efforts\, support translation of research into implementation\, and identify additional research needs. \nFourth Webinar: July 8th\, 3-5 pm ET\nImproving Early Detection of Hepatocellular Carcinoma (HCC): The Quest for New Biomarkers\nHosted by the National Cancer Institute \nCurrent guidelines (e.g. AASLD) recommend biannual (every 6 months) surveillance for hepatocellular carcinoma (HCC)\, usually using ultrasound (US) which may or may not include measuring the marker\, AFP (alpha-fetoprotein). This is recommended for certain chronic liver diseases (e.g. HBV infected individuals) and also for individuals with cirrhosis. These surveillance recommendations achieve mixed results in their effectiveness for early detection of HCC. There is an unmet need to identify and implement more effective surveillance (e.g. imaging and biomarkers) for the early detection of HCC. This webinar will explore the challenges and opportunities for improving HCC surveillance. \nPresentations:\nGlobal Dimension of HCC and Epidemiology- Katherine McGlynn\, National Cancer Institute (NCI) \nHCC Surveillance Current Practices- Amit Singal\, UT Southwestern Medical Center \nBiomarkers for HCC- Anand Mehta\, Medical University of South Carolina \nRisk Assessment of HCC- Nabihah Tayob\, Dana-Farber Cancer Institute and Harvard Medical School \nBasic HCC Research: Mouse Models- Ray Chung\, Massachusetts General Hospital URL:https://hcvfreefl.org/event/moving-from-hepatitis-discovery-to-elimination-nih-webinar-series-on-research-advancing-hepatitis-elimination-2/ END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211015T110000 DTEND;TZID=UTC:20211016T140000 DTSTAMP:20260525T214845 CREATED:20211004T164442Z LAST-MODIFIED:20211004T164442Z UID:649-1634295600-1634392800@hcvfreefl.org SUMMARY:ALF Liver Cancer Conference DESCRIPTION:We are two weeks away from our 2nd Annual Liver Cancer Conference presented by Exelixis! If you are living with liver cancer\, or care for someone with liver cancer be sure to register now here: https://t.co/Ma36NxOx1r ! You won't want to miss this.#LiverCancer #Caregiver pic.twitter.com/dU9LAGm2gF \nā€” American Liver Foundation National (@liverUSA) October 2\, 2021 URL:https://hcvfreefl.org/event/alf-liver-cancer-conference/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211020T090000 DTEND;TZID=UTC:20211022T170000 DTSTAMP:20260525T214845 CREATED:20211004T170456Z LAST-MODIFIED:20211004T170456Z UID:659-1634720400-1634922000@hcvfreefl.org SUMMARY:Fast-Track Cities 2021 Conference DESCRIPTION:Tune in to the @FastTrackCities to hear from our Chief Executive @caryjameslondon on hepatitis elimination! \nšŸ—“ļø 20 October 2021ā°9:30 ā€“ 1045 AM Lisbon \nLink: https://t.co/DcLUd8Uioq https://t.co/yuoLOQYSpW \nā€” World Hepatitis Alliance (@Hep_Alliance) September 29\, 2021 URL:https://hcvfreefl.org/event/fast-track-cities-2021-conference/ LOCATION:Feria Internacional de Lisboa\, R. do Bojador\, Lisboa\, 1998-010\, Portugal END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211020T120000 DTEND;TZID=UTC:20211020T130000 DTSTAMP:20260525T214845 CREATED:20210818T150955Z LAST-MODIFIED:20210818T150955Z UID:591-1634731200-1634734800@hcvfreefl.org SUMMARY:HARM HCV Elimination Program Virtual Series DESCRIPTION:THIS WEEK ā€“ JUNE 16 ā€“ @ProjectECHO presents HARM: Hepatitis\, Addiction & Stigma Reduction in Medicine\, an interactive series addressing the syndemic of Opioids and Hepatitis in America\, with a focus on drug use\, hepatitis C\, & Harm Reduction. Sign up: https://t.co/LBSoMWofVx \nā€” NVHR (@NVHR1) June 15\, 2021 URL:https://hcvfreefl.org/event/harm-hcv-elimination-program-virtual-series-3/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211021T163000 DTEND;TZID=UTC:20211021T173000 DTSTAMP:20260525T214845 CREATED:20211021T134104Z LAST-MODIFIED:20211021T134104Z UID:686-1634833800-1634837400@hcvfreefl.org SUMMARY:Hepatitis C Training Series Session 2 DESCRIPTION:#Clinicians! Tune in #Thursday #October 21\, 2021 4:30-5:30pm ET for #HepC Training Series\, Session #2: #HepatitisC Treatment with Dr. Sonal Kumar. \nSign up: https://t.co/3bpZ0p6qRa \nEarn FREE #CME #CNE #CEU. #LiverCancerAwarenessMonth #LCAM #LiverTwitter #Viral #Hepatitis pic.twitter.com/z7MmpAWiaE \nā€” Empire Liver Foundation (@LiverEmpire) October 13\, 2021 URL:https://hcvfreefl.org/event/hepatitis-c-training-series-session-2/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211021T180000 DTEND;TZID=UTC:20211021T210000 DTSTAMP:20260525T214845 CREATED:20211011T222454Z LAST-MODIFIED:20211011T222454Z UID:664-1634839200-1634850000@hcvfreefl.org SUMMARY:American Liver Foundation 45th Anniversary National Legacy Gala DESCRIPTION:Our 45th Anniversary National Legacy Gala will feature health advocate physicians\, authors & siblings: Dr.@sanjiv_chopra Professor of Medicine at @harvardmed & alternative medicine advocate\, @DeepakChopra\, MD. To learn more & support\, visit the link here: https://t.co/fCRqOYDNyi pic.twitter.com/PaXKHDYRfB \nā€” American Liver Foundation National (@liverUSA) October 9\, 2021 URL:https://hcvfreefl.org/event/american-liver-foundation-45th-anniversary-national-legacy-gala/ LOCATION:Gotham Hall\, 1356 Broadway at 36th Street\, New York\, NY\, 10018\, United States END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211021T190000 DTEND;TZID=UTC:20211021T200000 DTSTAMP:20260525T214845 CREATED:20211004T164934Z LAST-MODIFIED:20211004T165249Z UID:651-1634842800-1634846400@hcvfreefl.org SUMMARY:Empire Liver Foundation HCV Update Webinar DESCRIPTION:šŸ“£šŸšØ#Clinicians! #LiverTwitter! šŸ“£šŸšØ \nCheck out what October 2021 šŸ—“#HepatitisUpdates #webinars has lined up. \nLearn more about #HDV #HBV #HCV.https://t.co/smRVP9eiQK \nFor more clinical šŸ„¼trainings like these check out https://t.co/lddSs9aIlj pic.twitter.com/Xs4fRrubEW \nā€” Empire Liver Foundation (@LiverEmpire) October 1\, 2021 URL:https://hcvfreefl.org/event/empire-liver-foundation-hcv-update-webinar/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211022T080000 DTEND;TZID=UTC:20211022T170000 DTSTAMP:20260525T214845 CREATED:20211021T133814Z LAST-MODIFIED:20211021T133814Z UID:684-1634889600-1634922000@hcvfreefl.org SUMMARY:EASL Beating Liver Cancer In Europe DESCRIPTION:#LiverTwitter\, how can we truly tackle #livercancer? \nāš ļøāš ļøThis urgent problem calls for urgent solutions! \nšŸ‘‰Join our event: EASL-@EuropeLiver #BeatingLiverCancerĀ in Europe under the patronage of Slovenian presidency @EU2021SI \nRegister now! https://t.co/QD2muvGj5N \nā€” EASLnews (@EASLnews) October 21\, 2021 URL:https://hcvfreefl.org/event/easl-beating-liver-cancer-in-europe/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211026T133000 DTEND;TZID=UTC:20211026T143000 DTSTAMP:20260525T214845 CREATED:20211022T210236Z LAST-MODIFIED:20211022T210236Z UID:702-1635255000-1635258600@hcvfreefl.org SUMMARY:Virtual Liver Cancer Tumor Board Discussion DESCRIPTION:Join us on Tuesday October 26 at 1:30PM ET for a Virtual #LiverCancer Tumor Board Discussion with 6 medical experts discussing the complex challenges in providing treatment & care for those living with #HCC. A live Q&A session will follow. šŸ‘‰To Register: https://t.co/BLWg7lCZva pic.twitter.com/YSJazLrPGI \nā€” Global Liver Institute (@GlobalLiver) October 18\, 2021 URL:https://hcvfreefl.org/event/virtual-liver-cancer-tumor-board-discussion/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211027T120000 DTEND;TZID=UTC:20211027T130000 DTSTAMP:20260525T214845 CREATED:20211025T204158Z LAST-MODIFIED:20211025T204158Z UID:725-1635336000-1635339600@hcvfreefl.org SUMMARY:Breakthrough Treatment Options in Liver Cancer DESCRIPTION:Join us on Wednesday at 12:00PM ET/6:00PM CEST for another episode of #GLILIVE.In this episode\, our host\, Donna Cryer\, is joined by guest Dr. Maria Reig\, Head of Barcelona-Clinic #Liver Cancer to discuss Breakthrough Treatment Options in #LiverCancer. #OctoberIs4Livers pic.twitter.com/yrYfoyEjoa \nā€” Global Liver Institute (@GlobalLiver) October 25\, 2021 URL:https://hcvfreefl.org/event/breakthrough-treatment-options-in-liver-cancer/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20211027T180000 DTEND;TZID=Europe/Paris:20211027T190000 DTSTAMP:20260525T214845 CREATED:20211025T152311Z LAST-MODIFIED:20211025T152411Z UID:712-1635357600-1635361200@hcvfreefl.org SUMMARY:EASL Studio Episode 1: Liver Cancer Awareness Month DESCRIPTION:Join us Wed\, 27 October from 6 PM CET and watch the first episode of the new EASL Studio. \nEpisode one is dedicated to raising awareness about liver cancer during the #livercancerawarenessmonth. \nBookmark this page: https://t.co/dfEXvGavca @ThomasBerg24 @NaultJc @HepatoEpi pic.twitter.com/nYBy1Elkyf \nā€” EASLnews (@EASLnews) October 25\, 2021 URL:https://hcvfreefl.org/event/easl-studio-episode-1/ LOCATION:Virtual END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211028T080000 DTEND;TZID=UTC:20211029T170000 DTSTAMP:20260525T214845 CREATED:20210922T173326Z LAST-MODIFIED:20210922T173326Z UID:627-1635408000-1635526800@hcvfreefl.org SUMMARY:EASL-AASLD HCC Endpoints Conference DESCRIPTION:Register now for the @EASLnews & @AASLDtweets HCC Endpoints Conference. https://t.co/XYcCw7hf40#LiverTwitter #GITwitter \nā€” AASLD (@AASLDtweets) September 21\, 2021 URL:https://hcvfreefl.org/event/easl-aasld-hcc-endpoints-conference/ END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211028T163000 DTEND;TZID=UTC:20211028T173000 DTSTAMP:20260525T214845 CREATED:20211021T141522Z LAST-MODIFIED:20211025T163505Z UID:694-1635438600-1635442200@hcvfreefl.org SUMMARY:Hepatitis C Clinical Training Series Session 3 DESCRIPTION:#DYK that #HepC is a leading cause of #HepatoCellularCarcimona? #Thursday Dr. Jesudian discusses #HepatitisC Complications. https://t.co/uoIESdd7lH#October = #Liver #Cancer #AwarenessMonth pic.twitter.com/RW4wzWSFSL \nā€” Empire Liver Foundation (@LiverEmpire) October 25\, 2021 URL:https://hcvfreefl.org/event/hepatitis-c-clinical-training-series-session-3/ END:VEVENT BEGIN:VEVENT DTSTART;TZID=UTC:20211029T110000 DTEND;TZID=UTC:20211029T120000 DTSTAMP:20260525T214845 CREATED:20211025T164737Z LAST-MODIFIED:20211025T164737Z UID:719-1635505200-1635508800@hcvfreefl.org SUMMARY:PSC and Hepatic Fibrosis Webinar DESCRIPTION:This webinar will coincide with PSC Awareness Day. We will highlight PSC in terms of disease pathology and curative options open to patients suffering from PSC. \nFeaturing @RickySafer @heatherleefran @DrCynthiaLevy and more. \nRegister: https://t.co/tnu6YD3XJx pic.twitter.com/2cuU771DlC \nā€” AASLD (@AASLDtweets) October 25\, 2021 URL:https://hcvfreefl.org/event/psc-and-hepatic-fibrosis-webinar/ LOCATION:Virtual END:VEVENT END:VCALENDAR